ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $680.56 million. The enterprise value is $504.62 million.

Market Cap	680.56M
Enterprise Value	504.62M

Important Dates

The last earnings date was Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

AVBP has 34.05 million shares outstanding. The number of shares has increased by 316.83% in one year.

Current Share Class	34.05M
Shares Outstanding	34.05M
Shares Change (YoY)	+316.83%
Shares Change (QoQ)	+0.54%
Owned by Insiders (%)	2.62%
Owned by Institutions (%)	54.20%
Float	15.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.36
P/TBV Ratio	3.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.34, with a Debt / Equity ratio of 0.00.

Current Ratio	14.34
Quick Ratio	13.59
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -49.00% and return on invested capital (ROIC) is -33.71%.

Return on Equity (ROE)	-49.00%
Return on Assets (ROA)	-32.30%
Return on Invested Capital (ROIC)	-33.71%
Return on Capital Employed (ROCE)	-69.32%
Revenue Per Employee	n/a
Profits Per Employee	-$2.45M
Employee Count	52
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.94%
50-Day Moving Average	19.76
200-Day Moving Average	24.96
Relative Strength Index (RSI)	49.76
Average Volume (20 Days)	160,514

Short Selling Information

The latest short interest is 5.36 million, so 15.76% of the outstanding shares have been sold short.

Short Interest	5.36M
Short Previous Month	5.36M
Short % of Shares Out	15.76%
Short % of Float	33.81%
Short Ratio (days to cover)	21.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-140.41M
Pretax Income	n/a
Net Income	-127.46M
EBITDA	n/a
EBIT	-140.41M
Earnings Per Share (EPS)	-$3.78

Full Income Statement

Balance Sheet

The company has $176.08 million in cash and $138,000 in debt, giving a net cash position of $175.94 million or $5.17 per share.

Cash & Cash Equivalents	176.08M
Total Debt	138,000
Net Cash	175.94M
Net Cash Per Share	$5.17
Equity (Book Value)	202.54M
Book Value Per Share	5.95
Working Capital	172.83M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-119.59M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-316.83%
Shareholder Yield	-316.83%
Earnings Yield	-18.73%
FCF Yield	n/a

Analyst Forecast

The average price target for AVBP is $39.00, which is 95.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.00
Price Target Difference	95.10%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	10.28%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1